Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lithium rescues synaptic plasticity and memory in Down syndrome mice
Andrea Contestabile, … , Fabio Benfenati, Laura Gasparini
Andrea Contestabile, … , Fabio Benfenati, Laura Gasparini
Published December 3, 2012
Citation Information: J Clin Invest. 2013;123(1):348-361. https://doi.org/10.1172/JCI64650.
View: Text | PDF
Research Article Neuroscience

Lithium rescues synaptic plasticity and memory in Down syndrome mice

  • Text
  • PDF
Abstract

Down syndrome (DS) patients exhibit abnormalities of hippocampal-dependent explicit memory, a feature that is replicated in relevant mouse models of the disease. Adult hippocampal neurogenesis, which is impaired in DS and other neuropsychiatric diseases, plays a key role in hippocampal circuit plasticity and has been implicated in learning and memory. However, it remains unknown whether increasing adult neurogenesis improves hippocampal plasticity and behavioral performance in the multifactorial context of DS. We report that, in the Ts65Dn mouse model of DS, chronic administration of lithium, a clinically used mood stabilizer, promoted the proliferation of neuronal precursor cells through the pharmacological activation of the Wnt/β-catenin pathway and restored adult neurogenesis in the hippocampal dentate gyrus (DG) to physiological levels. The restoration of adult neurogenesis completely rescued the synaptic plasticity of newborn neurons in the DG and led to the full recovery of behavioral performance in fear conditioning, object location, and novel object recognition tests. These findings indicate that reestablishing a functional population of hippocampal newborn neurons in adult DS mice rescues hippocampal plasticity and memory and implicate adult neurogenesis as a promising therapeutic target to alleviate cognitive deficits in DS patients.

Authors

Andrea Contestabile, Barbara Greco, Diego Ghezzi, Valter Tucci, Fabio Benfenati, Laura Gasparini

×

Figure 5

Lithium restored the number of proliferating cells and increased the number of amplifying progenitors in Ts65Dn mice.

Options: View larger image (or click on image) Download as PowerPoint
Lithium restored the number of proliferating cells and increased the num...
(A) Ki67 immunoreactivity (green) and nuclei counterstaining with Hoechst-33342 (blue). Scale bar:100 μm. (B) Number of Ki67-stained cells. Proliferating cells were reduced in saline-treated Ts65Dn mice. Lithium treatment for 4 weeks significantly increased the number of Ki67+ cells in WT mice (black bars) and restored their number to physiological levels in Ts65Dn mice (white bars). 2-way ANOVA: genotype (F1,20 = 8.383, P = 0.009), treatment (F1,20 = 21.493, P < 0.001), genotype × treatment (F1,20 = 1.029, P = 0.322). (C) RGL progenitors (arrowheads) and amplifying progenitors (arrows) immunoreactive for GFAP (red) and Sox2 (green) and counterstained with Hoechst-33342 (blue). Scale bar: 25 μm. (D and E) Number of RGL progenitors and amplifying progenitors was evaluated by counting GFAP- and Sox2-positive cells with or without radial morphology (see Methods). (D) Number of RGL progenitors in lithium- or saline-treated mice showed no differences across groups. 2-way ANOVA: genotype (F1,20 = 0.261, P = 0.615), treatment (F1,20 = 0.364, P = 0.553), genotype × treatment (F1,20 = 0.746, P = 0.398). (E) Number of amplifying progenitors was reduced in Ts65Dn mice and significantly increased by lithium treatment. 2-way ANOVA: genotype (F1,20 = 17.155, P < 0.001), treatment (F1,20 = 2.772, P = 0.112), genotype × treatment (F1,20 = 4.217, P = 0.053). *P < 0.05; **P < 0.01, Tukey’s post hoc test. Numbers in parentheses indicate the number of animals analyzed in each group.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts